About us

Who we are

SK-Pharma core business of pharmaceutical companies with a clear mission to improve the wellbeing of habitants around the world.

Its core business is first to launch complex and non-infringing generic medicines in the markets of interest, such as Israel & Palestinian Authority and LATAM, as well as to give access to the program, which provides novel drugs to patients around the globe. Additionally, the company provide access Patient Support Program to rear, unique and hard to get products to thousands of patients globally.
Therefore, the company is divided into several territories that synergistically engaged to support the mission of improving and saving lives.

Drug shortages division with special capabilities to foresee shortages in various countries with the company unique smart machine and data management tool (GDS), renders SK-Pharma with the agility to leverage cutting edge technologies towards smart right on time solution for drug shortages mitigation and supply.

SK-Pharma is divided into numerous subsidiaries that in the field of business development, business intelligence, IP & litigations and creative Regulatory Affairs to profoundly support the company aim to lead the pharmaceutical industry in the markets of interest.

Shlomo Sadoun

CEO

shutterstock_253945318

Our worldwide offices

Our company has its representative offices in 7 countries and its strategic partners in more than 50 countries around the world.

The company’s growth engine is driven by global generics.

7Worldwide
offices
shlomi CEO

Ksenia Sizov
Dragana Baltezarevic
image user
 Yossi Shmeterer

Meet our
leadership team

SK-Pharma core business is first to launch complex and non-infringing generic medicines in the market of interest. Drug shortages division with special capabilities to foreseen shortages in various countries with the company unique smart machine and data management tool (GDS), that render SK-Pharma with the agility to leverage cutting edge technologies towards smart right on time solution for drug shortages mitigation and supply. Patient access programs, that provide novel drugs to patient in needs around the globe.

70Global
employees
shlomi CEO

Ksenia Sizov
Dragana Baltezarevic
image user
 Yossi Shmeterer

What we do

  • SK-Pharma core business is first to launch complex and non-infringing generic medicines in the market of interest
  • Drug shortages division with special capabilities to foreseen shortages in various countries with the company unique smart machine and data management tool (GDS), that render SK-Pharma with the agility to leverage cutting edge technologies towards smart right on time solution for drug shortages mitigation and supply
  • Patient access program, that provide novel drugs to patient in needs around the globe
240Marketed products

About us

Join our team

A family owned business that operates in the emerging pharmaceutical field must hold it’s unique value proposition that mobilizes the organization towards success, led by excellent individuals that gather towards a noble cause that represent their beliefs.

In SK-Pharma we encourage organizational culture driven by teamwork, innovation, out of the box thinking and agility. Putting the patient and the caregivers in the center by structuring around them a circle of trust and efficient solutions to support their needs.

up icon